Form 8-K Epizyme, Inc. For: Nov 06

Go back to Form 8-K Epizyme, Inc. For: Nov 06

Epizyme (EPZM) Misses Q3 EPS by 3c

November 6, 2014 7:43 AM EST

Epizyme (NASDAQ: EPZM) reported Q3 EPS of ($0.58), $0.03 worse than the analyst estimate of ($0.55). Revenue for the quarter came in at $8.2 million versus the consensus estimate of $7 million.

For earnings history and earnings-related data on Epizyme (EPZM) click here.

... More